Related references
Note: Only part of the references are listed.Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
An-Ping Shi et al.
FRONTIERS IN IMMUNOLOGY (2022)
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
Malgorzata Bajor et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy
Ha Gyeong Shin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade
Aixian Zheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
A Novel Sushi-IL15-PD1 CAR-NK92 Cell Line With Enhanced and PD-L1 Targeted Cytotoxicity Against Pancreatic Cancer Cells
Da-Lai Xu et al.
FRONTIERS IN ONCOLOGY (2022)
Review Article Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody
Dain Moon et al.
IMMUNE NETWORK (2022)
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
May Daher et al.
BLOOD (2021)
Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy
S. Tahmasebi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity
Hind Rafei et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
NK cells-directed therapies target circulating tumor cells and metastasis
Hassan Dianat-Moghadam et al.
CANCER LETTERS (2021)
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes
Jie Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
Chia-Ing Jan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Ying Gong et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non-small cell lung cancer patients with epidermal growth factor receptor mutation
Lin Ma et al.
CANCER COMMUNICATIONS (2021)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2+1 Common Light Chain Antibody Architecture
Jan P. Bogen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
Maxwell Y. Lee et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment
Stefan Grote et al.
CELLS (2021)
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments
Olivier Demaria et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab
Prasad S. Adusumilli et al.
CANCER DISCOVERY (2021)
Advancing to the era of cancer immunotherapy
Yun Wang et al.
CANCER COMMUNICATIONS (2021)
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
Emily J. Pomeroy et al.
MOLECULAR THERAPY (2020)
A novel bispecific chimeric PD1-DAP10/NKG2D receptor augments NK92-cell therapy efficacy for human gastric cancer SGC-7901 cell
Mingfeng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells
Tatsuki Ueda et al.
CANCER SCIENCE (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells
Cancers Ipilimuma et al.
CANCERS (2020)
IL-12 regulates the expansion, phenotype, and function of murine NK cells activated by IL-15 and IL-18
Naoto Oka et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
A Humanized Lym-1 CAR with Novel DAP10/DAP12 Signaling Domains Demonstrates Reduced Tonic Signaling and Increased Antitumor Activity in B-Cell Lymphoma Models
Long Zheng et al.
CLINICAL CANCER RESEARCH (2020)
Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
Ji-Yoon Noh et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Gene modification strategies for next-generation CAR T cells against solid cancers
Yonggui Tian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Immune-related adverse events of checkpoint inhibitors
Manuel Ramos-Casals et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
Helen Kotanides et al.
MOLECULAR CANCER THERAPEUTICS (2020)
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
Kellsye P. Fabian et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
Amy J. Petty et al.
CANCERS (2020)
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
Margery Gang et al.
BLOOD (2020)
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
Yvette Robbins et al.
ELIFE (2020)
Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer
Shuo Yang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
Cai Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Human NK-92 Cells Function as Target Cells for Human NK Cells - Implications for CAR NK-92 Therapies
Hans Bergman et al.
ANTICANCER RESEARCH (2020)
A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis
Chengui Lu et al.
MOLECULAR IMMUNOLOGY (2020)
Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines
Ji-Eun Park et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
B7-H3, a checkpoint molecule, as a target for cancer immunotherapy
Shuo Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells
Shin Hwang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
Lin Xiao et al.
MOLECULAR THERAPY (2019)
Engineering and Design of Chimeric Antigen Receptors
Sonia Guedan et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
Gaurav Nayyar et al.
FRONTIERS IN ONCOLOGY (2019)
When CAR Meets Stem Cells
Jung Min Lee
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221
Anna V. Tinker et al.
CLINICAL CANCER RESEARCH (2019)
Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer
Martin Cornillet et al.
GASTROENTEROLOGY (2019)
Inflammasome inhibitors: promising therapeutic approaches against cancer
Shengchao Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector
Wenjuan Dong et al.
CANCER DISCOVERY (2019)
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Daniela Pende et al.
FRONTIERS IN IMMUNOLOGY (2019)
Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity
Barbara Seliger
FRONTIERS IN IMMUNOLOGY (2019)
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More
Massimo Vitale et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human natural killer cells mediate adaptive immunity to viral antigens
Rana Nikzad et al.
SCIENCE IMMUNOLOGY (2019)
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
Shengnan Yu et al.
MOLECULAR CANCER (2019)
Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity
Xiaojuan Shi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells
Changjiang Guo et al.
MOLECULAR IMMUNOLOGY (2019)
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
Wenyan Fu et al.
NATURE COMMUNICATIONS (2019)
The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
Haoyu Sun et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
Katsiaryna Marhelava et al.
CANCERS (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
Michelle L. Saetersmoen et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
Robin Parihar et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis
Cathal Harmon et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells
Michael Chrobok et al.
CANCERS (2019)
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
Duaa O. Khair et al.
FRONTIERS IN IMMUNOLOGY (2019)
Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells
Chun-Hua Wu et al.
JOURNAL OF EXTRACELLULAR VESICLES (2019)
Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies
Michael D. Jain et al.
STEM CELLS (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
May Daher et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Role of T cell-derived exosomes in immunoregulation
Jian Lu et al.
IMMUNOLOGIC RESEARCH (2018)
Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T
Dok Hyun Yoon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects
Yuki Kagoya et al.
NATURE MEDICINE (2018)
Memory responses of innate lymphocytes and parallels with T cells
Moritz Rapp et al.
SEMINARS IN IMMUNOPATHOLOGY (2018)
Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts
Daniel Torralba et al.
NATURE COMMUNICATIONS (2018)
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
Dhifaf Sarhan et al.
CANCER IMMUNOLOGY RESEARCH (2018)
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity
Amelia Roman Aguilera et al.
ONCOIMMUNOLOGY (2018)
Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression
Pilar M. Lanuza et al.
ONCOIMMUNOLOGY (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
Bin Han et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel et al.
FRONTIERS IN IMMUNOLOGY (2018)
NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy
Dominik Schmiedel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
Nayoung Kim et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
Warm up, cool down, and tearing apart in NK cell memory
Lawrence Shih-Hsin Wu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens
Daniel M. Altmann
IMMUNOLOGY (2018)
TIM-3, a promising target for cancer immunotherapy
Yayi He et al.
ONCOTARGETS AND THERAPY (2018)
PD-L1 Mediates Dysfunction in Activated PD-1(+) NK Cells in Head and Neck Cancer Patients
Fernando Concha-Benavente et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Francesco Di Virgilio et al.
NATURE REVIEWS CANCER (2018)
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies
Paulina Nowakowska et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
NK cell education via nonclassical MHC and non-MHC ligands
Yuke He et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3
Murali Janakiram et al.
IMMUNOLOGICAL REVIEWS (2017)
Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma
Adam Lynch et al.
IMMUNOLOGY (2017)
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
Silvia Pesce et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
Julia A. Wagner et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
Laura Chiossone et al.
SEMINARS IN IMMUNOLOGY (2017)
NK cell-based immunotherapy for cancer
Fang Fang et al.
SEMINARS IN IMMUNOLOGY (2017)
Autologous lymphapheresis for the production of chimeric antigen receptor T cells
Elizabeth S. Allen et al.
TRANSFUSION (2017)
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
Jonas R. M. Van Audenaerde et al.
ONCOTARGET (2017)
Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
Liya Zhu et al.
THERANOSTICS (2017)
Generation of Off-the-Shelf Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
Jieming Zeng et al.
STEM CELL REPORTS (2017)
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer immunotherapy: Recent innovations and Future Developments
John P. Veluchamy et al.
FRONTIERS IN IMMUNOLOGY (2017)
Modeling Human Natural Killer cell Development in the era of innate Lymphoid cells
Steven D. Scoville et al.
FRONTIERS IN IMMUNOLOGY (2017)
Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
Anushruti Sarvaria et al.
FRONTIERS IN IMMUNOLOGY (2017)
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tumor-priming converts NK cells to memory-like NK cells
Marina Pal et al.
ONCOIMMUNOLOGY (2017)
CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
Thivyan Thayaparan et al.
ONCOIMMUNOLOGY (2017)
Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors
Si Li et al.
CLINICAL CANCER RESEARCH (2017)
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma
Sarah Oelsner et al.
CYTOTHERAPY (2017)
The Principles of Engineering Immune Cells to Treat Cancer
Wendell A. Lim et al.
CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
DNA methyltransferases and their roles in tumorigenesis
Wu Zhang et al.
BIOMARKER RESEARCH (2017)
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
Kemal Catakovic et al.
CELL COMMUNICATION AND SIGNALING (2017)
Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells
Ambrose Y. Jong et al.
JOURNAL OF EXTRACELLULAR VESICLES (2017)
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy
Garnet Suck et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors
Xunlei Kang et al.
CELL CYCLE (2016)
Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
David L. Hermanson et al.
STEM CELLS (2016)
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Petra S. A. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells
Dhifaf Sarhan et al.
CANCER RESEARCH (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Leonid Cherkassky et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells
Qi Gao et al.
CELL DEATH & DISEASE (2016)
Aptamers: A promising chemical antibody for cancer therapy
Gang Zhou et al.
ONCOTARGET (2016)
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
Caroline Jochems et al.
ONCOTARGET (2016)
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Asma Beldi-Ferchiou et al.
ONCOTARGET (2016)
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
Claudia Cantoni et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Features of Memory-Like and PD-1+ Human nK Cell Subsets
Mariella Della Chiesa et al.
FRONTIERS IN IMMUNOLOGY (2016)
Natural killer cell immunotherapy to target stem-like tumor cells
Steven K. Grossenbacher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Cord Blood as a Source of natural Killer Cells
Rohtesh S. Mehta et al.
FRONTIERS IN MEDICINE (2016)
Harnessing the immune system to improve cancer therapy
Nikos E. Papaioannou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Luis Martinez-Lostao et al.
CLINICAL CANCER RESEARCH (2015)
TRUCKs: the fourth generation of CARs
Markus Chmielewski et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
Heinrich Schlums et al.
IMMUNITY (2015)
Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals
Jaewon Lee et al.
IMMUNITY (2015)
The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer
Zhenxin Wang et al.
IMMUNOLOGICAL INVESTIGATIONS (2015)
TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells
Valentina Folgiero et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Erik Ames et al.
JOURNAL OF IMMUNOLOGY (2015)
DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
Katrin Toepfer et al.
JOURNAL OF IMMUNOLOGY (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Ex Vivo-expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
Susann Szmania et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
Naoyuki Sakamoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
Xiaojuan Liu et al.
NATURE MEDICINE (2015)
Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors
Hideo Komita et al.
ONCOLOGY REPORTS (2015)
Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment
Jennifer A. Juno et al.
RETROVIROLOGY (2015)
Inhibitory leukocyte immunoglobulin-like receptors in cancer development
Zhang FeiFei et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery
Christian J. Buchholz et al.
TRENDS IN BIOTECHNOLOGY (2015)
Chemokine Receptor Expression on Normal Blood CD56+ NK-Cells Elucidates Cell Partners That Comigrate during the Innate and Adaptive Immune Responses and Identifies a Transitional NK-Cell Population
Margarida Lima et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Utilizing chimeric antigen receptors to direct natural killer cell activity
David L. Hermanson et al.
FRONTIERS IN IMMUNOLOGY (2015)
Role of tumor necrosis factor superfamily in neuroinflammation and autoimmunity
Sandip Sonar et al.
FRONTIERS IN IMMUNOLOGY (2015)
Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer
Jeannette Cany et al.
ONCOIMMUNOLOGY (2015)
Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors
Joanne A. Hammill et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective
Cristina Eguizabal et al.
FRONTIERS IN IMMUNOLOGY (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schönfeld et al.
MOLECULAR THERAPY (2014)
T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy
Fatemeh Rahimi Jamnani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
Jeffrey W. Leong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
J. Kraan et al.
BRITISH JOURNAL OF CANCER (2014)
LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
Feng Xu et al.
CANCER RESEARCH (2014)
Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications
Lorenzo Moretta et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2014)
At the Bedside: Adoptive cell therapy for melanoma-clinical development
Jeffrey S. Weber
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J. Chan et al.
NATURE IMMUNOLOGY (2014)
NK cell self tolerance, responsiveness and missing self recognition
Nataliya Shifrin et al.
SEMINARS IN IMMUNOLOGY (2014)
Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy
Bronwen R. Burton et al.
NATURE COMMUNICATIONS (2014)
Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future
Javier Munoz et al.
STEM CELLS TRANSLATIONAL MEDICINE (2014)
The Dual Role of HLA-G in Cancer
Nathalie Rouas-Freiss et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Platform for Induction and Maintenance of Transgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells
Bahram Valamehr et al.
STEM CELL REPORTS (2014)
Are natural killer cells superior CAR drivers?
Hans Klingemann
ONCOIMMUNOLOGY (2014)
Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer
Rizwan Romee et al.
SCIENTIFICA (2014)
Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis
Giovanna Tabellini et al.
CASE REPORTS IN ONCOLOGY (2014)
Application of Aptamers for Targeted Therapeutics
Partha Ray et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
Michael Hudecek et al.
CLINICAL CANCER RESEARCH (2013)
Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Andres Wiernik et al.
CLINICAL CANCER RESEARCH (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy
Satiro Nakamura De Oliveira et al.
HUMAN GENE THERAPY (2013)
Natural killer cell biology: An update and future directions
Kerry S. Campbell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
Georg Gasteiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
James D. Mellor et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
Subhashis Sarkar et al.
PLOS ONE (2013)
Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
Nina Shah et al.
PLOS ONE (2013)
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
David A. Knorr et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Characterization and ex vivo expansion of human placenta-derived natural killer cells for cancer immunotherapy
Lin Kang et al.
FRONTIERS IN IMMUNOLOGY (2013)
Innate lymphoid cells - a proposal for uniform nomenclature
Hergen Spits et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Deryk Loo et al.
CLINICAL CANCER RESEARCH (2012)
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Natalia Lapteva et al.
CYTOTHERAPY (2012)
Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD
Silke Wiesmayr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
Martha Luevano et al.
HUMAN IMMUNOLOGY (2012)
Immune Surveillance Properties of Human NK Cell-Derived Exosomes
Luana Lugini et al.
JOURNAL OF IMMUNOLOGY (2012)
Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
Bree Foley et al.
JOURNAL OF IMMUNOLOGY (2012)
Characterisation of Bovine Leukocyte Ig-like Receptors
Louise Hogan et al.
PLOS ONE (2012)
Ex Vivo Generated Natural Killer Cells Acquire Typical Natural Killer Receptors and Display a Cytotoxic Gene Expression Profile Similar to Peripheral Blood Natural Killer Cells
Dorit Lehmann et al.
STEM CELLS AND DEVELOPMENT (2012)
Natural killer cell lines in tumor immunotherapy
Min Cheng et al.
Frontiers of Medicine (2012)
Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells
Christian Kellner et al.
CANCER LETTERS (2011)
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
Markus Chmielewski et al.
CANCER RESEARCH (2011)
Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity by Utilizing Diverse Cellular Mechanisms
Zhenya Ni et al.
JOURNAL OF VIROLOGY (2011)
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
Jan Spanholtz et al.
PLOS ONE (2011)
Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor-Negative Natural Killer Cells after NKG2A and LIR-1 Blockade
Robert Godal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
Uwe Siegler et al.
CYTOTHERAPY (2010)
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
Chrystelle Brignone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses
Silke Paust et al.
NATURE IMMUNOLOGY (2010)
Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors
Brigitte Anliker et al.
NATURE METHODS (2010)
SEPSIS Calming the cytokine storm
Charlotte Harrison
NATURE REVIEWS DRUG DISCOVERY (2010)
Extracellular adenosine triphosphate and adenosine in cancer
J. Stagg et al.
ONCOGENE (2010)
Replicative potential of human natural killer cells
Hiroyuki Fujisaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Natural killer cell cytotoxicity: how do they pull the trigger?
Nicola J. Topham et al.
IMMUNOLOGY (2009)
IL-12-Dependent Inducible Expression of the CD94/NKG2A Inhibitory Receptor Regulates CD94/NKG2C+ NK Cell Function
Andrea Saez-Borderias et al.
JOURNAL OF IMMUNOLOGY (2009)
Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection
Qingquan Liu et al.
JOURNAL OF VIROLOGY (2009)
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: A prospective study
Luis F. Porrata et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells
Nathalie T. Joncker et al.
IMMUNOLOGICAL REVIEWS (2008)
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane
Scott T. James et al.
JOURNAL OF IMMUNOLOGY (2008)
Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy
Woo-Sung Chang et al.
JOURNAL OF IMMUNOLOGY (2008)
Cutting edge:: Priming of NK cells by IL-18
Julie Chaix et al.
JOURNAL OF IMMUNOLOGY (2008)
Natural killer cell recognition of missing self
Klas Karre
NATURE IMMUNOLOGY (2008)
Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34+ Progenitors Promoted by Membrane-Bound IL-15
Massimo Giuliani et al.
PLOS ONE (2008)
The contrasting role of B7-H3
Kimberly A. Hofmeyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines
Min Jung Kim et al.
TUMOR BIOLOGY (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Thierry Walzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases
B. Grzywacz et al.
LEUKEMIA (2007)
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection
Yan Zhang et al.
IMMUNOLOGY (2007)
Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses
Thierry Walzer et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells
Xi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
T cell- and B cell-independent adaptive immunity mediated by natural killer cells
JG O'Leary et al.
NATURE IMMUNOLOGY (2006)
Human natural killer cell development and biology
Sherif S. Farag et al.
BLOOD REVIEWS (2006)
High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G
S Preithner et al.
MOLECULAR IMMUNOLOGY (2006)
Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells
JM Roda et al.
CANCER RESEARCH (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity
PS Woll et al.
JOURNAL OF IMMUNOLOGY (2005)
Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation
ES Ng et al.
BLOOD (2005)
Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
M Kisielow et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
C Imai et al.
BLOOD (2005)
The role of extracellular spacer regions in the optimal design of chimeric immune receptors - Evaluation of four different scFvs and antigens
RD Guest et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Characterization of cord blood natural killer cells:: Implications for transplantation and neonatal infections
JH Dalle et al.
PEDIATRIC RESEARCH (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
CD28-mediated co-stimulation: A quantitative support for TCR signalling
O Acuto et al.
NATURE REVIEWS IMMUNOLOGY (2003)
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial
LJ Burns et al.
BONE MARROW TRANSPLANTATION (2003)
Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood
H Tanaka et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells
CP Kalberer et al.
BLOOD (2003)
A novel myeloid-like NK cell progenitor in human umbilical cord blood
SA Perez et al.
BLOOD (2003)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Multicolor-FISH analysis of a natural killer cell line (NK-92)
RAF MacLeod et al.
LEUKEMIA RESEARCH (2002)
KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential
M Faure et al.
JOURNAL OF IMMUNOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells
F Borrego et al.
MOLECULAR IMMUNOLOGY (2002)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
Tumor-specific T cell activation by recombinant immunoreceptors:: CD3ζ signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can ge integrated into one combined CD28/CD3ζ signaling receptor molecule
A Hombach et al.
JOURNAL OF IMMUNOLOGY (2001)
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92
G Maki et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells
Y Yu et al.
JOURNAL OF IMMUNOLOGY (2001)
Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain
K Ozaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
T cell activation by recombinant FcεRI γ-chain immune receptors:: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition
A Hombach et al.
GENE THERAPY (2000)
Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures
MC Giarratana et al.
EXPERIMENTAL HEMATOLOGY (2000)
Share Paper
